Skip to main content

Published locations for Ocrelizumab safety update: Encouraging rates of serious infection, malignancy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ocrelizumab safety update: Encouraging rates of serious infection, malignancy

User login

  • Reset your password
  • /content/ocrelizumab-safety-update-encouraging-rates-serious-infection-malignancy
  • /internalmedicinenews/article/166072/multiple-sclerosis/ocrelizumab-safety-update-encouraging-rates
  • /multiplesclerosishub/article/166072/multiple-sclerosis/ocrelizumab-safety-update-encouraging-rates
  • /internalmedicine/article/166072/multiple-sclerosis/ocrelizumab-safety-update-encouraging-rates
  • /neurology/article/166072/multiple-sclerosis/ocrelizumab-safety-update-encouraging-rates-serious
  • /neurology/msresourcecenter/article/166072/multiple-sclerosis/ocrelizumab-safety-update-encouraging
  • /breast-cancer-icymi/article/166072/multiple-sclerosis/ocrelizumab-safety-update-encouraging-rates
  • /b-cell-lymphoma-icymi/article/166072/multiple-sclerosis/ocrelizumab-safety-update-encouraging-rates
  • /clinicalneurologynews/article/166072/multiple-sclerosis/ocrelizumab-safety-update-encouraging-rates